NRC has just approved a resolution for a strategic partnership with Ladophar, aiming to enhance production capacity and develop new products. The two parties will share technologies, research, and the development of new pharmaceutical products. This agreement is expected to create new opportunities for both companies in market expansion and technological innovation. In the coming time, NRC and Ladophar will undertake steps to actualize the agreement, ensuring the achievement of set objectives.
Leave a Reply